Magniject 25%

For the treatment of hypomagnesaemia in cattle and sheep

Description

PDF Product Sheet MAGNIJECT

Composition
Magnesium Sulphate Heptahydrate 25% w/v
(equivalent to Magnesium Sulphate anhydrous 12,21% w/v)
Characteristics

When administered by subcutaneous injection the product corrects the ionic disturbance associated with hypomagnesaemia. Magnesium is an essential mineral involved in metabolism, muscle activity and nerve functions.

Indications

Indicated in the treatment of hypomagnesaemia in cattle and sheep.